You are here

Article info

Article menu

Download PDFPDF

Rheumatoid arthritis
Review
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis

Authors

  • Laure Gossec Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS), Paris, FranceDepartment of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Maxime Dougados Rheumatology Department, Paris Descartes University, Cochin Hospital, AP-HP, Paris, FranceINSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France PubMed articlesGoogle scholar articles
  • William Dixon Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Laure Gossec; laure.gossec{at}psl.aphp.fr
View Full Text

Citation

Gossec L, Dougados M, Dixon W
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis
RMD Open 2015;1:e000019. doi: 10.1136/rmdopen-2014-000019

Publication history

  • Received February 16, 2015
  • Revision received March 10, 2015
  • Accepted March 11, 2015
  • First published April 2, 2015.
Online issue publication 
October 26, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/